Moreau, P. Dimopoulos, M.A. Yong, K. Mikhael, J. Risse, M.-L. Asset, G. Martin, T., Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study design, Future Oncology, (16), 4347-4358, 2019, Future Medicine Ltd, 1479-6694, 1744-8301